Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C49H66N10O10S2.2C2H4O2 |
Molecular Weight | 1139.343 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(O)=O.CC(O)=O.[H][C@]1(NC(=O)[C@H](CCCCN)NC(=O)[C@@H](CC2=CNC3=C2C=CC=C3)NC(=O)[C@H](CC4=CC=CC=C4)NC(=O)[C@H](CSSC[C@H](NC1=O)C(=O)N[C@H](CO)[C@@H](C)O)NC(=O)[C@H](N)CC5=CC=CC=C5)[C@@H](C)O
InChI
InChIKey=QWFYIFWTVZFPRY-LODIGNQBSA-N
InChI=1S/C49H66N10O10S2.2C2H4O2/c1-28(61)39(25-60)56-48(68)41-27-71-70-26-40(57-43(63)34(51)21-30-13-5-3-6-14-30)47(67)54-37(22-31-15-7-4-8-16-31)45(65)55-38(23-32-24-52-35-18-10-9-17-33(32)35)46(66)53-36(19-11-12-20-50)44(64)59-42(29(2)62)49(69)58-41;2*1-2(3)4/h3-10,13-18,24,28-29,34,36-42,52,60-62H,11-12,19-23,25-27,50-51H2,1-2H3,(H,53,66)(H,54,67)(H,55,65)(H,56,68)(H,57,63)(H,58,69)(H,59,64);2*1H3,(H,3,4)/t28-,29-,34-,36+,37+,38-,39-,40+,41+,42+;;/m1../s1
Molecular Formula | C49H66N10O10S2 |
Molecular Weight | 1019.239 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 10 / 10 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Molecular Formula | C2H4O2 |
Molecular Weight | 60.052 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 18:23:04 UTC 2023
by
admin
on
Sat Dec 16 18:23:04 UTC 2023
|
Record UNII |
75R0U2568I
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C62799
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
826221
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
||
|
EU-Orphan Drug |
EU/3/13/1170
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
606217
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
886622
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
||
|
FDA ORPHAN DRUG |
286509
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
75R0U2568I
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
DTXSID601027489
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
79517-01-4
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
100000091587
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
622838-44-2
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
MAJOR COMPONENT STRUCTURE/SEQUENCE | |||
|
1477604
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
m8121
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | Merck Index | ||
|
BB-25
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
760176-26-9
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
MAJOR COMPONENT STRUCTURE/SEQUENCE | |||
|
155804637
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
CHEMBL1680
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
C53447
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
SUB03490MIG
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
DBSALT000130
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | |||
|
221130
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY | RxNorm | ||
|
75R0U2568I
Created by
admin on Sat Dec 16 18:23:04 UTC 2023 , Edited by admin on Sat Dec 16 18:23:04 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
PARENT -> SALT/SOLVATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |